Gloom and Doom Meeting of docs Turns Hopeful When Patient Offers Health Reform Proposal
In Brief: Bresnick Directs Norris Cotton Cancer Center; FASEB Honors Kirschstein; Van Nevel’s 2th Year
Bosnian Research Trying To Leave, Asks For More Calls
ACS Urges Practice Of Insurance Exclusion End Under Reform
Epstein Petition Seeks Broder’s Removal As NCI Director
NIH Should Review CRADA Pricing, Wyden Write to Shalala
IOM Selects Advisors To Defense Department
“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy
FDA Policy On Support Of Medical Education Near Final Form
Trending Stories
- How the 2024 elections can impact cancer policy
- Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S. - GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation
- Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- At his 25-year “anniversary party,” Pazdur invites Califf and past FDA commissioners to talk about political interference
- “Less Radical” podcast: Resistance to change, a data scandal